Eric Dobmeier - 19 Jul 2024 Form 4 Insider Report for Janux Therapeutics, Inc. (JANX)

Reporting relationship: Director
Issuer ticker: JANX
Reported as of: 19 Jul 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Jul 2024, 20:04:42 UTC
Prior SEC filing: 27 Jun 2024
Next SEC filing: 01 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Janes Pennington, Attorney-in-Fact

Key filing fact

Eric Dobmeier filed Form 4 for Janux Therapeutics, Inc. (JANX) on 22 Jul 2024.

Key facts

This page summarizes Eric Dobmeier's Form 4 filing for Janux Therapeutics, Inc. (JANX).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 22 Jul 2024, 20:04.

Change

Previous filing in this sequence was filed on 27 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

JANX transaction

Common Stock

Award

Transaction value: $0
Shares: +5,000
Change %
Price: $0.000000
Shares after: 5,000
Date: 19 Jul 2024
Ownership: Direct
Footnotes: F1

JANX transaction

Common Stock

Award

Transaction value: $0
Shares: +2,500
Change %: +50%
Price: $0.000000
Shares after: 7,500
Date: 19 Jul 2024
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

JANX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +16,700
Change %
Price: $0.000000
Shares after: 16,700
Date: 19 Jul 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,700
Exercise price: $44.68
Footnotes: F3

JANX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +8,350
Change %
Price: $0.000000
Shares after: 8,350
Date: 19 Jul 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,350
Exercise price: $44.68
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in thirty-six equal monthly installments over a three year period, subject to the Reporting Person's continuous service on each such date.

Footnote F2

Represents the grant of RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on July 19, 2025, subject to the Reporting Person's continuous service on such date.

Footnote F3

The shares subject to the option will vest in thirty-six equal monthly installments over three years, subject to the Reporting Person's continuous service on each such date.

Footnote F4

The shares subject to the option will vest in twelve equal monthly installments over one year, subject to the Reporting Person's continuous service on each such date.